The University of Colorado at Denver and Health Sciences Center (UCDHSC) Pharmacology Graduate Training Program, currently in its 30th year of NIGMS funding, requests annual support for nine predoctoral students during the next five years. This Graduate Training Program distinguishes itself by providing a highly interactive environment, on a new HSC campus, in which students can obtain a broadly-based integrative perspective of science, training in the foundation of knowledge that defines pharmacology, and sophistication in specialized, state-of-the-art research areas. The Training Program is directed by Nancy Zahniser, Ph.D., and co-directed by David Port, Ph.D., who also chairs the Graduate Training Committee, which provides the day-to-day oversightover this Training Program. The 38 members of the Training Program faculty are drawn both from within and from outside of the Department of Pharmacology, School of Medicine, and have been recruited to provide broad, multidisciplinary training opportunities in neuropharmacology, cell signaling and trafficking, molecular pharmacology, pharmacogenetics, cancer biology, genomics, proteomics, lipidomics, biomolecular structure, bioinformatics, as well as translational pharmacology. The Training Program faculty are all accomplished, committed researchers and mentors with significant extramural funding. The sources of students entering this Training Program include direct applicants to the Program, as well as students who transition from HSC 'feeder'programs (Biomedical Sciences Program and Medical Scientist Training Program). The Pharmacology Graduate Training Program has three curricular tracks: pharmacology (primary track), biomolecular structure and bioinformatics. Hallmarks of the Program are a comprehensive didactic component, three laboratory rotations, a strong emphasis on student presentations in seminar settings, and a wide choice of thesis research options. Career development in the pharmacological sciences and student initiative are also emphasized. Since its last review, 42 students (from a total of 58) have been supported by this Training Grant, of which 10% came from under-represented populations. The Training Program currently has 27 students. Twenty-three trainees have graduated with Ph.D. degrees, on average, in five years. The competitiveness of the students for individual national fellowships, high quality publications in peer-reviewed journals and invitationsto participate in national meetings are all measures by which the successful training of the students is gauged. Additionally,the retention of the graduates in academic, industry and government positions is another measure of the success of the Training Program. With renewal of funding, this Training Program will continue to thrive and meet the national demands for individuals, trained as pharmacologists, who are individually astute researchers, can be multidisciplinary research team members, and also have the breadth of knowledge to plan and communicate effectively across a spectrum of technologies.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007635-35
Application #
8494424
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Okita, Richard T
Project Start
1978-07-01
Project End
2014-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
35
Fiscal Year
2013
Total Cost
$164,489
Indirect Cost
$12,735
Name
University of Colorado Denver
Department
Pharmacology
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Riedel, Simone S; Haladyna, Jessica N; Bezzant, Matthew et al. (2016) MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia. J Clin Invest 126:1438-50
Sinnen, Brooke L; Bowen, Aaron B; Gibson, Emily S et al. (2016) Local and Use-Dependent Effects of β-Amyloid Oligomers on NMDA Receptor Function Revealed by Optical Quantal Analysis. J Neurosci 36:11532-11543
Sasse, Sarah K; Altonsy, Mohammed O; Kadiyala, Vineela et al. (2016) Glucocorticoid and TNF signaling converge at A20 (TNFAIP3) to repress airway smooth muscle cytokine expression. Am J Physiol Lung Cell Mol Physiol 311:L421-32
Goodall, Megan L; Fitzwalter, Brent E; Zahedi, Shadi et al. (2016) The Autophagy Machinery Controls Cell Death Switching between Apoptosis and Necroptosis. Dev Cell 37:337-49
Spiltoir, Jessica I; Strickland, Devin; Glotzer, Michael et al. (2016) Optical Control of Peroxisomal Trafficking. ACS Synth Biol 5:554-60
Kraft, Monica; Gerber, Anthony N; Szefler, Stanley J et al. (2016) Introduction to the 58th Annual Thomas L. Petty Aspen Lung Conference: Asthma 2015: Mechanisms to Personalized Medicine. Ann Am Thorac Soc 13 Suppl 1:S23-4
Goodspeed, Andrew; Heiser, Laura M; Gray, Joe W et al. (2016) Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics. Mol Cancer Res 14:3-13
Agarwal, Neeraj; Dancik, Garrett M; Goodspeed, Andrew et al. (2016) GON4L Drives Cancer Growth through a YY1-Androgen Receptor-CD24 Axis. Cancer Res 76:5175-85
Barcomb, Kelsey; Hell, Johannes W; Benke, Tim A et al. (2016) The CaMKII/GluN2B Protein Interaction Maintains Synaptic Strength. J Biol Chem 291:16082-9
Shimizu, Kaori; Quillinan, Nidia; Orfila, James E et al. (2016) Sirtuin-2 mediates male specific neuronal injury following experimental cardiac arrest through activation of TRPM2 ion channels. Exp Neurol 275 Pt 1:78-83

Showing the most recent 10 out of 58 publications